Presentations by Wayne Hancock

• Tue-05 from 16:30 - 17:45 in room 12
  From Pre-Clinical Studies to First in Human: What's New on the Horizon
  Five Strategies to Use IL-2 Muteins to Expand Foxp3+ Treg Cells and Promote Long-Term Cardiac and Renal Allograft Survival in Naïve and Sensitized Recipients